Key Events This Week
18 May: Stock opens at Rs.554.80, down 3.61% amid broader market weakness
20 May: Golden Cross formation signals potential bullish breakout
21 May: Mojo Grade upgraded from Sell to Hold on improved fundamentals
22 May: Bullish momentum shift drives 5.77% daily gain to Rs.622.30

Shree Ganesh Remedies Ltd Sees Bullish Momentum Shift Amid Technical Upgrades
2026-05-22 08:03:55Shree Ganesh Remedies Ltd has witnessed a notable shift in its technical momentum, with key indicators signalling a transition from mildly bullish to bullish territory. The stock’s recent price surge, coupled with upgraded technical grades and improved momentum metrics, suggests growing investor confidence in this micro-cap pharmaceutical player.
Read full news article
Shree Ganesh Remedies Ltd Upgraded to Hold on Improved Financial and Technical Trends
2026-05-21 08:24:05Shree Ganesh Remedies Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a stabilisation in its financial performance and a shift towards a more positive technical outlook. The upgrade, effective from 20 May 2026, is driven by improvements across four key parameters: quality, valuation, financial trend, and technical indicators, signalling cautious optimism for investors in this micro-cap pharmaceutical player.
Read full news article
Shree Ganesh Remedies Ltd Shows Technical Momentum Shift Amid Mixed Market Signals
2026-05-21 08:04:07Shree Ganesh Remedies Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bearish stance to a mildly bullish outlook. Despite a slight dip in the stock price on 21 May 2026, the evolving technical indicators suggest a nuanced market sentiment for this micro-cap pharmaceutical player, warranting close attention from investors and analysts alike.
Read full news article
Golden Cross Forms in Shree Ganesh Remedies Ltd — On a Day the Stock Fell 0.66%. What the Mixed Signals Mean
2026-05-20 18:00:37The 50-day moving average has crossed above the 200-day moving average for Shree Ganesh Remedies Ltd, signalling a golden cross on 20 May 2026. Yet, the stock declined 0.66% on the same day, while monthly momentum indicators remain bearish. This juxtaposition of signals invites a closer examination of the technical and fundamental context behind the crossover.
Read full news articleShree Ganesh Remedies Gains 8.48%: Mixed Quarterly Results and Volatile Week
2026-05-16 13:00:04
Key Events This Week
May 11: Stock opens at Rs.517.10, down 2.54% amid broad market weakness
May 12: Continued decline to Rs.504.05 (-2.52%) as Sensex falls sharply
May 13: Stabilisation at Rs.503.90 (-0.03%) with Sensex modestly up
May 14: Further dip to Rs.498.40 (-1.09%) despite Sensex gains
May 15: Sharp rally to Rs.575.60 (+15.49%) following mixed quarterly results
Are Shree Ganesh Remedies Ltd latest results good or bad?
2026-05-15 19:27:34Shree Ganesh Remedies Ltd's latest financial results for Q4 FY26 present a complex picture of operational performance. The company achieved a notable revenue of ₹33.20 crores, reflecting a year-on-year growth of 35.90%, which is a significant recovery from the previous year's decline. This revenue figure marks the highest quarterly sales in recent history, indicating strong sequential momentum following a challenging Q3 FY26. However, despite the robust revenue growth, the company's profitability metrics show a contrasting trend. The net profit for the quarter was ₹6.27 crores, which represents a decline of 4.86% compared to the same quarter last year. This decline in net profit occurs even as the company experienced a dramatic 102.91% recovery from the previous quarter, highlighting a disconnect between top-line growth and bottom-line performance. The operating margin has contracted to 34.28%, down from ...
Read full news article
Shree Ganesh Remedies Ltd Reports Mixed Quarterly Results Amid Shifting Financial Trends
2026-05-15 15:00:32Shree Ganesh Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported its March 2026 quarter results reflecting a nuanced financial performance. While net sales and operating profits reached record highs, key profitability metrics and financial ratios indicate emerging challenges, signalling a shift from a previously flat to a negative financial trend.
Read full news articleAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript
20-May-2026 | Source : BSETranscript of Earnings Call
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
16-May-2026 | Source : BSEAudio Recording - Earnings Call held on May 15 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
15-May-2026 | Source : BSENewspaper Publication
Corporate Actions
No Upcoming Board Meetings
Shree Ganesh Remedies Ltd has declared 5% dividend, ex-date: 07 Sep 23
No Splits history available
Shree Ganesh Remedies Ltd has announced 1:5 bonus issue, ex-date: 01 Nov 21
Shree Ganesh Remedies Ltd has announced 7:100 rights issue, ex-date: 03 Feb 23







